ClinVar Miner

Submissions for variant NM_130839.5(UBE3A):c.2124+9T>C

gnomAD frequency: 0.00454  dbSNP: rs79328837
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV000144346 SCV001711964 benign Angelman syndrome 2021-03-26 reviewed by expert panel curation The allele frequency of the c.2064+9T>C variant in UBE3A is 0.4% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions. Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4). In summary, the c.2064+9T>C variant in UBE3A is classified as benign based on the ACMG/AMP criteria (BA1, BP4).
GeneDx RCV000082346 SCV000169715 benign not specified 2016-06-20 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genetic Services Laboratory, University of Chicago RCV000082346 SCV000195359 benign not specified 2017-06-22 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000082346 SCV000333389 benign not specified 2015-07-28 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000144346 SCV000559149 benign Angelman syndrome 2024-01-27 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000858258 SCV001146578 benign not provided 2018-12-27 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000858258 SCV004033361 benign not provided 2024-07-01 criteria provided, single submitter clinical testing UBE3A: BS1, BS2
Breakthrough Genomics, Breakthrough Genomics RCV000858258 SCV005297380 benign not provided criteria provided, single submitter not provided
Baylor Genetics RCV000144346 SCV000188523 uncertain significance Angelman syndrome 2014-02-14 no assertion criteria provided clinical testing possible diagnosis of Angelman syndrome
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000082346 SCV001931594 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000082346 SCV001953711 benign not specified no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003925078 SCV004743586 benign UBE3A-related disorder 2019-05-09 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.